Alector (ALEC) Gains from Sales and Divestitures (2018 - 2025)
Alector (ALEC) reported Gains from Sales and Divestitures of $4.0 million for Q4 2025, up 32.03% year-over-year from $3.0 million in Q4 2024, and up 32.03% quarter-over-quarter from $3.0 million in Q4 2024.
Alector (ALEC) Gains from Sales and Divestitures (2018 - 2025) Analysis & Trends
Alector (ALEC) has 8 years of Gains from Sales and Divestitures data on file, last reported at $4.0 million in Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $4.0 million, up 32.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.0 million (up 32.03% YoY), and the FY2025 annual result was $4.0 million, up 32.03% from the prior year.
- Gains from Sales and Divestitures advanced to $4.0 million in Q4 2025 per ALEC's latest filing, from $3.0 million in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $4.0 million in Q4 2025 and troughed at $85544.0 in Q1 2021.
- A 5-year average of $873407.3 and a median of $323868.0 in 2023 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2021 and 2023: Gains from Sales and Divestitures sank 63.0% in 2021, then jumped 282.18% in 2023.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $324802.0 in 2021, then climbed by 27.64% to $414577.0 in 2022, then jumped by 282.18% to $1.6 million in 2023, then soared by 89.41% to $3.0 million in 2024, then soared by 32.03% to $4.0 million in 2025.
- Business Quant data shows ALEC's Gains from Sales and Divestitures at $4.0 million in Q4 2025, $3.0 million in Q4 2024, and $1.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.96 Mn |
| Dec 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Jun 30, 2023 | 663,123.00 |
| Jun 30, 2023 | 663,123.00 |
| Mar 31, 2023 | 323,868.00 |
| Mar 31, 2023 | 323,868.00 |
| Dec 31, 2022 | 414,577.00 |
| Dec 31, 2022 | 414,577.00 |
| Sep 30, 2022 | 307,204.00 |
| Sep 30, 2022 | 307,204.00 |
| Jun 30, 2022 | 205,444.00 |
| Jun 30, 2022 | 205,444.00 |
| Mar 31, 2022 | 104,368.00 |
| Mar 31, 2022 | 104,368.00 |
| Dec 31, 2021 | 324,802.00 |
| Dec 31, 2021 | 324,802.00 |